Item 2.02 Results of Operations and Financial Condition.

The information set forth under this "Item 2.02. Results of Operations and Financial Condition," including the exhibit attached hereto, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.

Attached as Exhibit 99.1 is a copy of a press release of Cyclacel Pharmaceuticals, Inc. (the "Company"), dated May 11, 2023, announcing certain financial results for the first quarter ended March 31, 2023.

The Company will conduct a conference call to review its financial results on May 11, 2023, at 4:30 p.m., Eastern Time.

Item 9.01 Financial Statements and Exhibits.






(d) Exhibits.




Exhibit
No.        Description

  99.1       Press release announcing financial results for the first quarter
           ended March 31, 2023, dated May 11, 2023.

104        Cover Page Interactive Data File (embedded with the Inline XBRL
           document).

© Edgar Online, source Glimpses